All News about Gilead Sciences





Looking Into Gilead Sciences's Recent Short Interest
November 22, 2023
Via Benzinga

$100 Invested In This Stock 20 Years Ago Would Be Worth $1,000 Today
November 21, 2023
Via Benzinga


Gilead Sciences's Options: A Look at What the Big Money is Thinking
November 15, 2023
Via Benzinga


FDA Approves AstraZeneca's Truqap/Faslodex Combo Therapy For Breast Cancer, Competes With Gilead's Drug
November 17, 2023
Via Benzinga
Exposures
Product Safety



A Closer Look at Gilead Sciences's Options Market Dynamics
November 09, 2023
Via Benzinga

Where Gilead Sciences Stands With Analysts
November 09, 2023
Via Benzinga

Via Benzinga

Kite and Arcellx Announce Expansion in Strategic Partnership
November 15, 2023
Via Business Wire




Gilead Sciences to Present at Upcoming Investor Conferences
November 08, 2023
Via Business Wire

Gilead Sciences (GILD) Q3 2023 Earnings Call Transcript
November 07, 2023
Via The Motley Fool
Topics
Earnings
Exposures
Financial


Gilead Sciences Announces Third Quarter 2023 Financial Results
November 07, 2023
Via Business Wire




Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.